Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Xiaomin Liang & Yurong Lai. (2021) Overcoming the shortcomings of the extended-clearance concept: a framework for developing a physiologically-based pharmacokinetic (PBPK) model to select drug candidates involving transporter-mediated clearance. Expert Opinion on Drug Metabolism & Toxicology 17:8, pages 869-886.
Read now
Read now
Karen Rowland Yeo, Masoud Jamei & Amin Rostami-Hodjegan. (2013) Predicting drug–drug interactions: application of physiologically based pharmacokinetic models under a systems biology approach. Expert Review of Clinical Pharmacology 6:2, pages 143-157.
Read now
Read now
Karen Rowland Yeo, Mohsen Aarabi, Masoud Jamei & Amin Rostami-Hodjegan. (2011) Modeling and predicting drug pharmacokinetics in patients with renal impairment. Expert Review of Clinical Pharmacology 4:2, pages 261-274.
Read now
Read now
Articles from other publishers (10)
Phuong Thi Thu Nguyen, Md Masud Parvez, Min Jung Kim, Sung Eun Yoo, Sangzin Ahn, Jong‐Lyul Ghim & Jae‐Gook Shin. (2019) Physiologically Based Pharmacokinetic Modeling Approach to Predict Drug‐Drug Interactions With Ethionamide Involving Impact of Genetic Polymorphism on FMO3. The Journal of Clinical Pharmacology 59:6, pages 880-889.
Crossref
Crossref
Rodrigo Cristofoletti & Jennifer B. Dressman. (2016) Bridging the Gap Between In Vitro Dissolution and the Time Course of Ibuprofen-Mediating Pain Relief. Journal of Pharmaceutical Sciences 105:12, pages 3658-3667.
Crossref
Crossref
Barbara A. Wetmore. (2015) Quantitative in vitro-to-in vivo extrapolation in a high-throughput environment. Toxicology 332, pages 94-101.
Crossref
Crossref
Sebastian Polak, Barbara Wiśniowska, Kamil Fijorek, Anna Glinka & Aleksander Mendyk. (2014) In vitro–in vivo extrapolation of drug-induced proarrhythmia predictions at the population level. Drug Discovery Today 19:3, pages 275-281.
Crossref
Crossref
Barbara A. Wetmore & Russell S. Thomas. 2013. High‐Throughput Screening Methods in Toxicity Testing. High‐Throughput Screening Methods in Toxicity Testing
77
95
.
A Rostami-Hodjegan. (2012) Physiologically Based Pharmacokinetics Joined With In Vitro–In Vivo Extrapolation of ADME: A Marriage Under the Arch of Systems Pharmacology. Clinical Pharmacology & Therapeutics 92:1, pages 50-61.
Crossref
Crossref
Cyrus Ghobadi, Trevor N. Johnson, Mohsen Aarabi, Lisa M. Almond, Aurel Constant Allabi, Karen Rowland-Yeo, Masoud Jamei & Amin Rostami-Hodjegan. (2011) Application of a Systems Approach to the Bottom-Up Assessment of Pharmacokinetics in Obese Patients. Clinical Pharmacokinetics 50:12, pages 809-822.
Crossref
Crossref
Karen B Goetz, Michael Pfleiderer & Christian K Schneider. (2010) First-in-human clinical trials with vaccines—what regulators want. Nature Biotechnology 28:9, pages 910-916.
Crossref
Crossref
Masoud Jamei, Gemma L. Dickinson & Amin Rostami-Hodjegan. (2009) A Framework for Assessing Inter-individual Variability in Pharmacokinetics Using Virtual Human Populations and Integrating General Knowledge of Physical Chemistry, Biology, Anatomy, Physiology and Genetics: A Tale of ‘Bottom-Up’ vs ‘Top-Down’ Recognition of Covariates. Drug Metabolism and Pharmacokinetics 24:1, pages 53-75.
Crossref
Crossref
Hirotaka Ando, Shigeru Izawa, Wataru Hori & Ippei Nakagawa. (2008) Utility of a single adjusting compartment: a novel methodology for whole body physiologically-based pharmacokinetic modelling. Theoretical Biology and Medical Modelling 5:1.
Crossref
Crossref